Skip to main content

Table 4 Correlation between TSQM and 6MWD, medication administration time, and adverse events

From: Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

  Change in 6-minute walk distance* Percent change in medication administration time* Severity-weighted adverse event score
TSQM
  Effectiveness 0.43 (p = 0.0004) 0.04 (p = 0.79) −0.45 (p = 0.0002)
  Side effects 0.18 (p = 0.15) 0.18 (p = 0.17) −0.44 (p = 0.0002)
  Convenience 0.24 (p = 0.06) 0.14 (p = 0.28) −0.36 (p = 0.003)
  Global satisfaction 0.29 (p = 0.02) 0.14 (p = 0.30) −0.35 (p = 0.005)
  1. * Compared to change in TSQM from Baseline to Week 12.
  2. † Compared to TSQM at Week 12.
  3. Medication administration time missing data for 5 subjects.